

Breast Cancer in NJ
Hackensack Meridian Health’s breast cancer and breast imaging program offers New Jersey’s most comprehensive breast cancer care. Our experts deliver advanced and personalized breast cancer treatment options and we are proud to be part of Hackensack Meridian Health’s John Theurer Cancer Center at Hackensack University Medical Center, New Jersey's #1 and only nationally ranked cancer center by U.S. News & World Report 2026-2027.
Our goal is to help you navigate every aspect of your breast cancer diagnosis and treatment. We offer a wide range of breast health services, including breast cancer screenings,treatment, support and survivorship navigators, as well as care for benign breast diseases. We also provide genetic counseling and testing for those at high risk for breast cancer.
Screening and Diagnosis
Each of our imaging specialists have advanced training in breast imaging and only interpret breast images, providing them with laser-focused expertise. In addition to the services and resources below, view our Breast Health page for more information.
Find a Mammography Location Near You
Schedule a Mammogram Online
Treatment Options
Effective breast cancer treatment begins with a precise understanding of your specific tumor. Our approach to breast cancer care is centered on detailed tumor analysis, which allows us to identify the genetic and molecular characteristics of your cancer. This detailed profile guides your multidisciplinary team in developing a personalized treatment plan that may include targeted chemotherapy, hormonal therapy for ER+ or PR+ cancers, advanced radiation techniques, or a specific surgical approach.
Breast cancer treatments with Hackensack Meridian Health include:
- Chemotherapy
- Hormonal Therapy
- Radiation Therapy
- Breast Surgery
- Plastic Surgery
Screening FAQs
Treatment FAQs
Post-Treatment FAQs
Our Research and Clinical Trials
At Hackensack Meridian Health, you may have the opportunity to participate in a clinical trial of new and exciting approaches to stem cell transplant. Our research has a strong focus on reducing the complications of transplant and also lowering the risk of disease recurrence. We are the first in the world to combine checkpoint inhibitors (drugs that inhibit the proteins cancer cells use to evade detection by the immune system) after transplantation, at a time when the immune system has the best opportunity to eliminate any remaining cancer cells.

Rapid Breast Cancer Care Leads to Promising Prognosis
Meet Silvana

Fighting Breast Cancer to Win

How a Middletown Mom Overcame Stage Zero Breast Cancer at 38

Breast Cancer Questions Everyone Should Ask

Should You Get Genetic Testing for Breast Cancer?

What Does It Mean If You Have Dense Breasts?

